EVFM Evofem Biosciences Inc

Neothetics Inc is a clinical-stage pharmaceutical company developing therapeutics for the aesthetic market. Its product is a novel injectable treatment for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients.

$2.28
As of 03/05/2021     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Health Care
Biotechnology
USA
USA
11/20/2014
83,119,033
5,671,070
$189,511,395
0.00%
SEC Edgar Online
10-Q
10-K
30048L104
US30048L1044
BDRKBH7

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-6.34
134.12
681.70
-8,495.03%
-41,161.15%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy